FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:2650-2651 June 23, 2005 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Gilron, I. PubMed Citation

To the Editor: The cleverly designed and carefully conducted crossover trial reported by Gilron et al. (March 31 issue)¹ shows better control of neuropathic pain with the combination of morphine and gabapentin than with single agents or placebo. Although we admire the meticulousness of the investigators, we also marvel at the unusually rigid adherence of the majority of the patients to a demanding and complex drug regimen. We must conclude that this was a very select group of highly motivated and fastidious patients. It is likely that they had many more personality traits in common with one another than with . . . [Full Text of this Article]

This article has been cited by other articles:

• Jensen, T. S, Backonja, M.-M., Jimenez, S. H., Tesfaye, S., Valensi, P., Ziegler, D. (2006). New perspectives on the management of diabetic peripheral neuropathic pain. Diabetes and Vascular Disease Research 3: 108-119 [Abstract]